Screener
Collaborative Arrangement Specified Sales Level For Determining Royalty Rate
Innoviva, Inc.·Products & Services·1 segment
Breakdown
Segments
Long Acting Beta2Agonist Relvar BreoView metric
| Segment | Q1 '22 | Q1 '23 | Q1 '24 | Q1 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Long Acting Beta2Agonist Relvar Breo | $3B | $3B | $3B | $3B | $3B |
| Total | $3B | $3B | $3B | $3B | $3B |